Doheny, D., Sirkisoon, S., Rimkus, T., Zhu, D., Aguayo, N., Harrison, A., . . . Lo, H. (2019). BSCI-02. tGLI1 IS A NOVEL, ACTIONABLE TARGET FOR THE TREATMENT OF BREAST CANCER BRAIN METASTASES. Neurooncol Adv.
Citação norma ChicagoDoheny, Daniel, et al. "BSCI-02. TGLI1 IS A NOVEL, ACTIONABLE TARGET FOR THE TREATMENT OF BREAST CANCER BRAIN METASTASES." Neurooncol Adv 2019.
Citação norma MLADoheny, Daniel, et al. "BSCI-02. TGLI1 IS A NOVEL, ACTIONABLE TARGET FOR THE TREATMENT OF BREAST CANCER BRAIN METASTASES." Neurooncol Adv 2019.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.